Biotech

All Articles

Capricor reveals even more records for DMD therapy after initiating BLA

.Capricor Rehabs is actually taking a success lap for their phase 2 Duchenne muscle dystrophy (DMD) ...

FDA places Kezar lupus test in hold following 4 person deaths

.The FDA has actually positioned Kezar Lifestyle Sciences' lupus trial on hold after the biotech fla...

Phase 3 Intellectual Stone trial hits SMA target, delivering stock up 200%

.A stage 3 trial of Academic Stone's spine muscular degeneration (SMA) applicant has attacked its ma...

CAMP 4 is actually most up-to-date to eye IPO, while Upstream describe $182M planning

.RNA biotech CAMP4 Therapies has defined prepare for a $67 thousand IPO, along with inflammation-foc...

Galecto gets leukemia medication, drops bone tissue cancer possession in pivot

.A year after the failure of an idiopathic lung fibrosis prospect sent Galecto on a look for redempt...

Judo tosses down $100M to knock out renal condition

.Taking the mat is actually Judo Biography, an ambitious biotech armed with $one hundred million to ...

AstraZeneca pays for CSPC $100M for preclinical cardiovascular disease medication

.AstraZeneca has actually settled CSPC Drug Team $one hundred thousand for a preclinical heart disea...

Zephyrm looks for Hong Kong IPO to money period 3 tissue therapy trials

.Zephyrm Bioscience is gusting towards the Hong Kong stock exchange, filing (PDF) for an IPO to stak...

Frazier Lifestyle Sciences collects $630M for small, mid-cap biotechs

.Frazier Life Sciences has actually sourced a further $630 thousand for its own fund concentrated on...

GigaGen garners around $135M BARDA dollars to hammer botox

.Antibody aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its technicia...